Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639258 · ClinicalTrials.gov registry record · NA
Medtronic Evolut™ EXPAND TAVR I Feasibility Study
A NA study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04639258 is a NA study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 11 participants.
The verdict
NCT04639258, a NA study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of the study is to obtain safety and effectiveness data of the Medtronic Evolut™ PRO+ TAVR System for the treatment of severe, asymptomatic aortic stenosis.
Interventions
- DEVICE Medtronic Evolut™ PRO+ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-05-28 |
| Est. Completion | 2022-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04639258
The ClinicalTrials.gov registry entry for NCT04639258 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic Evolut™ PRO+ System is the first listed.
NCT04639258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04639258 about?
NCT04639258 is a clinical study titled "Medtronic Evolut™ EXPAND TAVR I Feasibility Study". The purpose of the study is to obtain safety and effectiveness data of the Medtronic Evolut™ PRO+ TAVR System for the treatment of severe, asymptomatic aortic stenosis.
What is the current status of trial NCT04639258?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2021-05-28. Estimated completion is 2022-06-07.
What interventions are being tested in trial NCT04639258?
The interventions under investigation include: Medtronic Evolut™ PRO+ System (DEVICE).
Who is sponsoring clinical trial NCT04639258?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.